Steven J Feigenberg

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi request reprint Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 62:956-64. 2005
  2. ncbi request reprint A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Am J Clin Oncol 29:458-62. 2006
  3. ncbi request reprint Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 62:397-405. 2005
  4. ncbi request reprint What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 61:1003-10. 2005
  5. ncbi request reprint A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Thorac Oncol 2:287-92. 2007
  6. ncbi request reprint Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation
    Steven J Feigenberg
    Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania 19111, USA
    J Appl Clin Med Phys 8:2268. 2007
  7. pmc A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant
    Thomas N Eade
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 71:338-45. 2008
  8. doi request reprint Increased recurrences using intensity-modulated radiation therapy in the postoperative setting
    Aruna Turaka
    Departments of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Am J Clin Oncol 33:599-603. 2010
  9. ncbi request reprint Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer
    Mark K Buyyounouski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 63:1455-62. 2005
  10. ncbi request reprint The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer
    David J D'Ambrosio
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 67:1082-7. 2007

Detail Information

Publications37

  1. ncbi request reprint Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 62:956-64. 2005
    ..To prospectively assess health-related quality of life (HRQOL) during the first year after treatment with prostate brachytherapy (PB) alone for T1c-2a prostate cancer...
  2. ncbi request reprint A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Am J Clin Oncol 29:458-62. 2006
    ..The purpose of this report is to determine whether any specific magnitude in the prostate specific antigen (PSA) bounce predicted for a clinically poorer outcome...
  3. ncbi request reprint Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 62:397-405. 2005
    ..To determine whether the use of androgen deprivation (AD) increases late morbidity when combined with high-dose three-dimensional conformal radiation therapy (3D-CRT)...
  4. ncbi request reprint What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 61:1003-10. 2005
    ..The purpose of this study was to determine what pretreatment (initial) PSA (iPSA) level, if any, warrants the addition of long-term androgen deprivation in the PSA era...
  5. ncbi request reprint A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Thorac Oncol 2:287-92. 2007
    ..To determine the feasibility of combining concurrent carboplatin/paclitaxel and thoracic radiotherapy (TRT) for completely resected stage II and IIIA non-small cell lung cancer...
  6. ncbi request reprint Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation
    Steven J Feigenberg
    Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania 19111, USA
    J Appl Clin Med Phys 8:2268. 2007
    ..The isocenter shifts generated by using a CT unit in the treatment room correlate highly with shifts produced by the BAT Ultrasound system...
  7. pmc A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant
    Thomas N Eade
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 71:338-45. 2008
    ..To compare the toxicity and biochemical outcomes of intensity-modulated radiation therapy (IMRT) and (125)I transperineal permanent prostate seed implant ((125)I) for patients with low-risk prostate cancer...
  8. doi request reprint Increased recurrences using intensity-modulated radiation therapy in the postoperative setting
    Aruna Turaka
    Departments of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Am J Clin Oncol 33:599-603. 2010
    ..To determine the pattern of failures following intensity modulated radiation therapy for head and neck cancer...
  9. ncbi request reprint Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer
    Mark K Buyyounouski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 63:1455-62. 2005
    ..To compare several characteristics of alternative definitions of biochemical failure (BF) in men with extended follow-up after radiotherapy (RT) with or with androgen deprivation therapy (ADT) for prostate cancer...
  10. ncbi request reprint The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer
    David J D'Ambrosio
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 67:1082-7. 2007
    ..To investigate the prognostic utility of the proportion of prostate biopsy tissue containing Gleason pattern 4 or 5 (GP4/5) after definitive radiotherapy (RT) for prostate cancer...
  11. ncbi request reprint Radiation therapy for angiosarcoma
    Jon R Ward
    Department of Radiation Oncology, University of Florida Health Science Center, 2000 SW Archer Rd, Gainesville, Florida 32608, USA
    Head Neck 25:873-8. 2003
    ..Between 1964 and 1998, 19 patients with histologically proven angiosarcoma were treated with curative intent with radiation therapy...
  12. ncbi request reprint Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?
    Stephen F Andrews
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer 104:299-304. 2005
    ..There are limited data on the consequences of radiation treatment delay. The purpose of the current study was to evaluate the effect of time to treatment (TTT) on outcomes...
  13. pmc Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer
    Aruna Turaka
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 79:65-70. 2011
    ..To determine differences in clinical outcomes using intensity-modulated radiotherapy (IMRT) or a standard low neck field (LNF) to treat low neck...
  14. pmc Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
    Alan Pollack
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 64:518-26. 2006
    ..The dosimetry and acute toxicity are described in the first 100 men enrolled in a randomized trial...
  15. ncbi request reprint Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection
    Daniel T Chang
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL 32610 0385, USA
    Int J Radiat Oncol Biol Phys 67:1043-51. 2007
    ..To determine the long-term outcome of a consistent treatment approach with electron beam postmastectomy radiation therapy (PMRT) in breast cancer patients with > or =10 positive nodes treated with combined-modality therapy...
  16. ncbi request reprint A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy
    Derek B Chism
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 59:380-5. 2004
    ..Two models for stratification of prostate cancer aggressiveness predominate for the purposes of daily treatment decision making. This study investigates the relationships between these two clinically popular models...
  17. ncbi request reprint Angiosarcoma after breast-conserving therapy
    Alan T Monroe
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida 32610 0385, USA
    Cancer 97:1832-40. 2003
    ..As more women undergo breast-conserving therapy, the incidence can be expected to increase. Surgeons, medical oncologists, and radiation oncologists will be faced with difficult management decisions for this aggressive disease...
  18. ncbi request reprint Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons
    Steven J Feigenberg
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA
    Int J Radiat Oncol Biol Phys 56:716-25. 2003
    ..To determine the patterns of failure and prognostic factors for locoregional recurrence after postmastectomy radiotherapy (RT), using a specific electron beam technique...
  19. ncbi request reprint Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report
    David J D'Ambrosio
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    J Neurooncol 85:77-9. 2007
    ..Prophylactic cranial irradiation (PCI) is commonly offered to patients with limited stage primary small cell lung cancer following a complete response...
  20. ncbi request reprint Prostate cancer radiotherapy dose response: an update of the fox chase experience
    Alan Pollack
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
    J Urol 171:1132-6. 2004
    ....
  21. ncbi request reprint Prostate cancer risk assessment program: a 10-year update of cancer detection
    Veda N Giri
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19012, USA
    J Urol 178:1920-4; discussion 1924. 2007
    ..Guidelines for screening men at high risk for prostate cancer remain under investigation. We report our 10-year cancer detection data from the Prostate Cancer Risk Assessment Program, a longitudinal screening program for men at high risk...
  22. doi request reprint Rectal dose variation during the course of image-guided radiation therapy of prostate cancer
    Lili Chen
    Radiation Oncology Department, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Radiother Oncol 95:198-202. 2010
    ..To investigate the change in rectal dose during the treatment course for intensity-modulated radiotherapy (IMRT) of prostate cancer with image-guidance...
  23. ncbi request reprint Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
    Noel M Kramer
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111 2497, USA
    Head Neck 27:406-14. 2005
    ..The purpose of this study is to report the initial clinical results of the Fox Chase phase I and II prospective reirradiation and chemotherapy studies...
  24. doi request reprint Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases...
  25. ncbi request reprint Oligodendroglioma: does deferring treatment compromise outcome?
    Steven J Feigenberg
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA
    Am J Clin Oncol 26:e60-6. 2003
    ....
  26. doi request reprint Increasing national mastectomy rates for the treatment of early stage breast cancer
    Usama Mahmood
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 20:1436-43. 2013
    ..To study national trends in the mastectomy rate for treatment of early stage breast cancer...
  27. doi request reprint Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer: the GammaPod™
    Yildirim D Mutaf
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Med Phys 40:041722. 2013
    ..This study presents the first evaluation of dosimetric and geometric characteristics from the initial prototype installed at University of Maryland Radiation Oncology Department...
  28. ncbi request reprint Celecoxib to decrease urinary retention associated with prostate brachytherapy
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Brachytherapy 2:103-7. 2003
    ..To retrospectively evaluate the effect of celecoxib in preventing urinary retention following prostate brachytherapy...
  29. ncbi request reprint Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report
    Edwina L Berman
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Neurosurgery 61:E1099; discussion E1099. 2007
    ..To present a rare case of a radiation-induced malignancy after stereotactic radiosurgery...
  30. doi request reprint Accelerated partial breast irradiation via brachytherapy: a patterns-of-care analysis with ASTRO consensus statement groupings
    Zain A Husain
    Department of Radiation Oncology, University of Maryland Medical System, Baltimore, MD 21201, USA
    Brachytherapy 10:479-85. 2011
    ..We performed a patterns-of-care analysis for patients undergoing breast brachytherapy and compared these results with the American Society for Radiation Oncology (ASTRO) consensus statement...
  31. ncbi request reprint Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy
    Steven J Feigenberg
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida 32610 0385, USA
    Int J Radiat Oncol Biol Phys 52:620-6. 2002
    ..To report our promising results of hyperfractionated radiotherapy (RT) in conjunction with surgery for angiosarcoma occurring after breast-conserving therapy for early-stage breast cancer...
  32. ncbi request reprint Radiosurgery for paraganglioma of the temporal bone
    Steven J Feigenberg
    Department of Radiation Oncology, University of Florida Health Science Center, PO Box 100385, Gainesville, FL 32610 0385, USA
    Head Neck 24:384-9. 2002
    ..To report the outcome of patients with paraganglioma of the temporal bone treated with stereotactic radiosurgery at the University of Florida...
  33. ncbi request reprint Non-small cell lung cancer
    David S Ettinger
    J Natl Compr Canc Netw 6:228-69. 2008
  34. ncbi request reprint In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046
    Mark K Buyyounouski
    Int J Radiat Oncol Biol Phys 60:1664-5; author reply 1666. 2004
  35. ncbi request reprint Androgen suppression plus radiation therapy for prostate cancer
    Eric M Horwitz
    JAMA 292:2084-5; author reply 2085. 2004
  36. ncbi request reprint Intensity-modulated radiotherapy for early larynx cancer: is there a role?
    Steven J Feigenberg
    Int J Radiat Oncol Biol Phys 68:2-3. 2007
  37. ncbi request reprint Non-small cell lung cancer clinical practice guidelines in oncology
    David S Ettinger
    J Natl Compr Canc Netw 4:548-82. 2006